Topics

Outcomes Superior for HM3 LVAD Regardless of Preimplant Strategy

14:00 EST 15 Jan 2020 | Drugs.com

WEDNESDAY, Jan. 15, 2020 -- For patients with advanced heart failure, the HeartMate 3 (HM3) left ventricular assist device (LVAD) is superior to the HeartMate II (HMII), regardless of whether the device is a bridge to transplant (BTT) or a...

Original Article: Outcomes Superior for HM3 LVAD Regardless of Preimplant Strategy

NEXT ARTICLE

More From BioPortfolio on "Outcomes Superior for HM3 LVAD Regardless of Preimplant Strategy"

Quick Search

Relevant Topic

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...